$GILD GILEAD SCIENCES INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in GILEAD SCIENCES INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
GILEAD SCIENCES INC Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Alton Gregg H | Chief Patient Officer | 58,046 | 4,244,904 | Mar 05 2019 | |||
| BARTON JACQUELINE K | Director | 15,676 | 1,146,386 | May 14 2021 | 23 months ago | ||
| BERG PAUL | Director | 36,864 | 2,695,864 | May 13 2011 | |||
| BISCHOFBERGER NORBERT W | EVP, R&D and CSO | 12,793 | 935,552 | Feb 23 2018 | |||
| BISCHOFBERGER NORBERT W | EVP, R&D and CSO | 165,168 | 12,078,736 | Feb 19 2015 | |||
| Bluestone Jeffrey | Director | 0 | 0 | May 14 2021 | 23 months ago | ||
| CARACCIOLO ANTHONY | SVP, Manufacturing | 0 | 0 | Jan 24 2007 | |||
| Carter Paul Rutherford | EVP Commercial Ops | 64,122 | 4,689,242 | Aug 03 2016 | |||
| Carter Paul Rutherford | EVP Commercial Ops | 45,439 | 3,322,954 | Feb 19 2015 | |||
| Cogan John Francis | Director | 57,276 | 4,188,594 | May 05 2020 | |||
| Cogan John Francis | Director | 13,213 | 966,267 | May 14 2012 | |||
| Cogan John Francis | Director | 42,405 | 3,101,078 | Dec 24 2014 | |||
| DAVIGNON ETIENNE | Director | 838,652 | 61,330,621 | May 10 2016 | |||
| DAVIGNON ETIENNE | Director | 600,391 | 43,906,594 | May 14 2012 | |||
| DAVIGNON ETIENNE | Director | 836,273 | 61,156,644 | May 08 2014 | |||
| DENNY JAMES M | Director | 191,800 | 14,026,334 | May 21 2008 | |||
| DENNY JAMES M | Director | 254,058 | 18,579,262 | Dec 20 2012 | |||
| Dickinson Andrew D | Chief Financial Officer | 32,907 | 2,406,489 | Mar 12 2021 | 25 months ago | ||
| DORSA CAROLINE | SVP, Chief Financial Officer | 0 | 0 | Dec 17 2007 | |||
| GILEAD SCIENCES INC | 10% Owner | 13,913,029 | 1,017,459,811 | Feb 02 2021 | |||
| Hamill Laura | EVP, Worldwide Commercial Ops | 9,840 | 719,599 | May 10 2019 | |||
| HILLS CARLA A | Director | 39,285 | 2,872,912 | May 10 2016 | |||
| HILLS CARLA A | Director | 9,968 | 728,960 | May 14 2012 | |||
| HILLS CARLA A | Director | 35,915 | 2,626,464 | May 08 2014 | |||
| HILLS CARLA A | Director | 121 | 8,849 | Apr 25 2007 | |||
| Horning Sandra | Director | 632 | 46,218 | Jan 29 2021 | |||
| INOUYE MICHAEL K | SVP | 0 | 0 | Jan 30 2004 | |||
| Kramer Kelly A. | Director | 1,339 | 97,921 | May 07 2020 | |||
| LANGE LOUIS G | EVP Cardiovascular Therapeutic | 0 | 0 | May 08 2009 | |||
| LEE WILLIAM A | SVP, Research | 58,399 | 4,270,719 | May 04 2007 | |||
| Lofton Kevin E | Director | 74,203 | 5,426,465 | Mar 31 2021 | 24 months ago | ||
| MADIGAN JOHN W | Director | 18,548 | 1,356,415 | May 11 2017 | |||
| MADIGAN JOHN W | Director | 7,412 | 542,040 | May 10 2010 | |||
| MADIGAN JOHN W | Director | 11,232 | 821,396 | May 14 2012 | |||
| MADIGAN JOHN W | Director | 13,391 | 979,284 | May 08 2014 | |||
| MANWANI HARISH | Director | 5,654 | 413,477 | May 07 2021 | 23 months ago | ||
| MARTIN JOHN C | Director | 2,885,507 | 211,017,127 | Feb 08 2019 | |||
| MARTIN JOHN C | Chairman and CEO | 4,255,876 | 311,232,212 | Feb 19 2015 | |||
| McHutchison John G | Chief Scientific Off/HeadR&D | 35,177 | 2,572,494 | Feb 08 2019 | |||
| Mercier Johanna | Chief Commercial Officer | 8,068 | 590,013 | May 05 2021 | 23 months ago | ||
| Metza Kristen | SVP, Human Resources | 4,118 | 301,149 | Jul 03 2008 | |||
| Metza Kristen | SVP, Human Resources | 25,305 | 1,850,555 | Nov 05 2012 | |||
| Meyers James R | EVP Worldwide Commercial Ops | 2,936 | 214,710 | Feb 23 2018 | |||
| MILLIGAN JOHN F | President and CEO | 1,574,306 | 115,128,998 | Nov 29 2018 | |||
| MILLIGAN JOHN F | President and COO | 1,029,108 | 75,258,668 | Feb 19 2015 | |||
| Montgomery Alan Bruce | SVP, Respiratory Therapeutics | 14,280 | 1,044,296 | Jan 24 2007 | |||
| MOORE GORDON EARLE | Director | 811,839 | 59,369,786 | May 14 2012 | |||
| MOORE GORDON EARLE | Director | 1,063,839 | 77,798,546 | Aug 16 2012 | |||
| MOORE NICHOLAS G | Director | 12,233 | 894,599 | Apr 02 2018 | |||
| MOORE NICHOLAS G | Director | 7,309 | 534,507 | May 14 2012 | |||
| MOORE NICHOLAS G | Director | 0 | 0 | Jul 30 2014 | |||
| O'Day Daniel Patrick | Chairman & CEO | 147,136 | 10,760,056 | Mar 12 2021 | 25 months ago | ||
| Parsey Merdad | Chief Medical Officer | 12,263 | 896,793 | Mar 12 2021 | 25 months ago | ||
| PERRY MARK L | EVP Operations | 5,600 | 409,528 | Feb 04 2004 | |||
| Pletcher Brett A | EVP,Corp Affairs & Gen Counsel | 29,166 | 2,132,910 | Mar 12 2021 | 25 months ago | ||
| Rodriguez Javier | Director | 1,838 | 134,413 | Jun 16 2021 | 22 months ago | ||
| SHULTZ GEORGE P | Director | 55,000 | 4,022,150 | Aug 10 2005 | |||
| TOOLE JOHN J | SVP, Clinical Research | 0 | 0 | Apr 26 2007 | |||
| Washington Robin L | EVP, CFO | 21,620 | 1,581,071 | Mar 14 2019 | |||
| Washington Robin L | EVP, CFO | 85,356 | 6,242,084 | Feb 19 2015 | |||
| WELTERS ANTHONY | Director | 0 | 0 | May 14 2021 | 23 months ago | ||
| Whitley Richard James | Director | 33,058 | 2,417,532 | May 07 2021 | 23 months ago | ||
| Whitley Richard James | Director | 15,641 | 1,143,826 | Feb 04 2015 | |||
| Wilfong Diane E | SVP, Controller & CAO | 19,434 | 1,421,208 | Mar 12 2021 | 25 months ago | ||
| WILSON GAYLE E | Director | 129,052 | 9,437,573 | May 07 2020 | |||
| WILSON GAYLE E | Director | 40,865 | 2,988,457 | Dec 03 2014 | |||
| WOLD OLSEN PER | Director | 102,060 | 7,463,648 | May 07 2021 | 23 months ago | ||
| WOLD OLSEN PER | Director | 88,173 | 6,448,091 | Feb 10 2015 | |||
| YANG TAIYIN | SVP, Pharm Dev & Mfg | 146,381 | 10,704,843 | May 02 2007 | |||
| YOUNG KEVIN | Chief Operating Officer | 16,152 | 1,181,196 | Feb 23 2018 |